Ethyl Acetate

Ethyl Acetate

SCHEMBL39633

CCOC(C)=O.CCOC(C)=O.CCOC(C)=O.CO.CO

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.93
LMNA P02545 1/20 0.93
HSD17B10 Q99714 1/20 0.93
TSHR P16473 2/20 0.55
GAA P10253 2/20 0.50
ALOX15 P16050 1/20 0.50
MGAM O43451 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
SOAT1 P35610 1/20 0.50
TRPA1 O75762 1/20 0.46
GLO1 Q04760 1/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
CHRM5 P08912 2/20 0.42
CHRM1 P11229 2/20 0.42
CHRM3 P20309 2/20 0.42
PGR P06401 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL1272759 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL543302 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7983781 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1243562 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6749269 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL1597168 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9199371 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL7846736 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL9844576 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA
Ethyl Acetate SCHEMBL6399468 1.00 ALDH1A1 (0.93) ALDH1A1LMNAHSD17B10TSHRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590656-B1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX INC (US) 2017-11-15 EP disclosed
EP-2591354-B1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX INC (US) 2016-09-07 EP disclosed
US-20130336920-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2013-12-19 US disclosed
EP-2590656-A2 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT Ardelyx, Inc. (US) 2013-05-15 EP disclosed
EP-2591354-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT Ardelyx, Inc. (US) 2013-05-15 EP disclosed
WO-2012054110-A2 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-04-26 WO disclosed
WO-2012006475-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT ARDELYX, INC. (US) 2012-01-12 WO disclosed
US-4293483-A PEPTIDE ANTIBIOTICS ELI LILLY AND COMPANY (US) 1981-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130336920-A1 COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT SLC34A2, SLC34A1, SLC10A2 ALDH1A1 2892/4885LMNA 2948/4885HSD17B10 2333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.